Skin Conditions & Dermatology Clinical Trials Update: Week 15, 2026

Published April 10, 2026 — 5 trials covered

By Victor Lafforgue, Founder of TrialsAlert

A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis

This Phase 3 trial is testing a new injection called SHR-1819 in adolescents with moderate-to-severe atopic dermatitis, a condition that causes red, itchy, and inflamed skin. The study is currently recruiting in China and focuses on young patients with significant symptoms. If successful, this treatment could provide a new way to improve skin health and reduce discomfort for adolescents dealing with this challenging skin condition.

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

This Phase 3 trial is evaluating zasocitinib, a medication aimed at children and teenagers with moderate-to-severe plaque psoriasis, a skin condition that leads to red, scaly patches. The study is recruiting participants aged 4 to under 18 years from multiple countries. Positive results could mean a new treatment option that helps control symptoms and is easier for young patients to manage over the long term.

MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

This study is exploring new imaging technologies to screen for melanoma, a serious type of skin cancer, along with other skin conditions like melanocytic nevus and skin carcinoma. Conducted at a single site in the United States with 17 participants, the research aims to develop simpler and non-invasive ways to detect melanoma early. Early detection is critical for better outcomes, so this could be an important step forward in skin cancer screening.

A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks

This trial compares two topical treatments, tacrolimus and crisaborole, in children and young adults aged 2 to 20 years with mild to moderate atopic dermatitis. The study is recruiting in Pakistan and aims to find which treatment offers the best balance between effectiveness and safety. Results could help patients and caregivers choose the most suitable option to manage this common skin condition with fewer side effects.

Sunflower and Olive Oils for Preventing Diaper Dermatitis in Hospitalized Infants

This study looked at whether applying sunflower or olive oil could prevent diaper rash in hospitalized infants receiving antibiotics. Conducted in Turkey with babies aged 0 to 24 months, the results are now available. If using these natural oils proves effective, it could offer a simple and gentle way to protect infants' sensitive skin from irritation during hospital stays.

TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.